Correlation Between Mink Therapeutics and Danakali

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mink Therapeutics and Danakali at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mink Therapeutics and Danakali into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mink Therapeutics and Danakali, you can compare the effects of market volatilities on Mink Therapeutics and Danakali and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mink Therapeutics with a short position of Danakali. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mink Therapeutics and Danakali.

Diversification Opportunities for Mink Therapeutics and Danakali

-0.07
  Correlation Coefficient

Good diversification

The 3 months correlation between Mink and Danakali is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Mink Therapeutics and Danakali in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Danakali and Mink Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mink Therapeutics are associated (or correlated) with Danakali. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Danakali has no effect on the direction of Mink Therapeutics i.e., Mink Therapeutics and Danakali go up and down completely randomly.

Pair Corralation between Mink Therapeutics and Danakali

Given the investment horizon of 90 days Mink Therapeutics is expected to under-perform the Danakali. But the stock apears to be less risky and, when comparing its historical volatility, Mink Therapeutics is 2.57 times less risky than Danakali. The stock trades about -0.39 of its potential returns per unit of risk. The Danakali is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  15.00  in Danakali on September 15, 2024 and sell it today you would earn a total of  1.00  from holding Danakali or generate 6.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy57.14%
ValuesDaily Returns

Mink Therapeutics  vs.  Danakali

 Performance 
       Timeline  
Mink Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mink Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's forward-looking signals remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Danakali 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Danakali has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Mink Therapeutics and Danakali Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mink Therapeutics and Danakali

The main advantage of trading using opposite Mink Therapeutics and Danakali positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mink Therapeutics position performs unexpectedly, Danakali can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Danakali will offset losses from the drop in Danakali's long position.
The idea behind Mink Therapeutics and Danakali pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years